Tonix Pharmaceuticals Holding (TNXP) Common Equity (2010 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Common Equity of $227.1 million for Q1 2026, up 25.91% year-over-year from $180.4 million in Q1 2025, and down 7.35% quarter-over-quarter from $245.2 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Common Equity (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Common Equity history runs 17 years deep, the most recent figure standing at $227.1 million for Q1 2026.
- In Q1 2026, Common Equity rose 25.91% year-over-year to $227.1 million; the TTM figure through Mar 2026 stood at $227.1 million (up 25.91% YoY), while the FY2025 annual figure was $245.2 million, up 75.66% from the prior year.
- Common Equity for Q1 2026 stood at $227.1 million, down from $245.2 million in the prior quarter.
- The five-year high for Common Equity was $245.2 million in Q4 2025, with the low at $42.1 million in Q2 2024.
- The 5-year median for Common Equity is $168.0 million (2025), against an average of $165.9 million.
- The sharpest annual moves came in 2024 and 2025: Common Equity tumbled 70.03% in 2024, then jumped 299.02% in 2025.
- Tonix Pharmaceuticals Holding's Common Equity stood at $207.2 million in 2022, then tumbled by 49.07% to $105.5 million in 2023, then surged by 32.25% to $139.6 million in 2024, then soared by 75.66% to $245.2 million in 2025, then retreated by 7.35% to $227.1 million in 2026.
- Business Quant data shows TNXP's Common Equity at $227.1 million in Q1 2026, $245.2 million in Q4 2025, and $231.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.61 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.17 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.79 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.35 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 757.49 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | 222.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 222.28 Mn |
| Mar 31, 2026 | 227.14 Mn |
| Dec 31, 2025 | 245.15 Mn |
| Sep 30, 2025 | 231.14 Mn |
| Jun 30, 2025 | 168.00 Mn |
| Mar 31, 2025 | 180.40 Mn |
| Dec 31, 2024 | 139.56 Mn |
| Sep 30, 2024 | 74.21 Mn |
| Jun 30, 2024 | 42.10 Mn |
| Mar 31, 2024 | 108.14 Mn |
| Dec 31, 2023 | 105.53 Mn |
| Sep 30, 2023 | 120.83 Mn |
| Jun 30, 2023 | 140.46 Mn |
| Mar 31, 2023 | 165.43 Mn |
| Dec 31, 2022 | 207.18 Mn |
| Sep 30, 2022 | 228.92 Mn |
| Jun 30, 2022 | 228.28 Mn |
| Mar 31, 2022 | 207.96 Mn |
| Dec 31, 2021 | 218.72 Mn |
| Sep 30, 2021 | 202.22 Mn |